Rationale for using recombinant human erythropoietin to treat the anemia of prematurity
Contrib Nephrol
.
1989:76:324-8; discussion 328-9.
doi: 10.1159/000417909.
Authors
R H Phibbs
1
,
K Shannon
,
W C Mentzer
Affiliation
1
Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco.
PMID:
2684531
DOI:
10.1159/000417909
No abstract available
Publication types
Review
MeSH terms
Anemia / blood
Anemia / drug therapy*
Anemia / therapy
Blood Transfusion
Erythropoietin / therapeutic use*
Hematocrit
Humans
Infant
Infant, Newborn
Infant, Premature
Substances
Erythropoietin